Skip to main content
. 2019 Oct;31(5):771–784. doi: 10.21147/j.issn.1000-9604.2019.05.07

S3.

S3

Survival analysis of CDH2-lower patients with stage II/III based on immunohistochemistry (IHC) of phosphoglucose isomerase (GPI). Kaplan-Meier (KM) plots of CDH2-lower patients in TNM II (P=4.8e−01) (A), TNM III (P=2.2e−01) (B), and TNM II/III (P=4.0e−01) (C), separated by GPI expression in protein level.